Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Schuitemaker

Showing results (61-70 of 92) with videos related to

Pageof 10
Sort By:
The Journal of Infectious Diseases|October 1, 1996
Changes in cellular virus load and zidovudine resistance of syncytium-inducing and non-syncytium-inducing human immunodeficiency virus populations under zidovudine pressure: a clonal analysisA B van 't Wout, M D de Jong, N A Kootstra, et al.
AIDS (London, England)|August 17, 1999
HIV-1 subtype C syncytium- and non-syncytium-inducing phenotypes and coreceptor usage among Ethiopian patients with AIDSA Abebe, D Demissie, J Goudsmit, et al.
Biologicals : Journal of the International Association of Biological Standardization|October 31, 2006
Viral safety of C1-inhibitor NFF G Terpstra, M Kleijn, A H L Koenderman, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|April 15, 1996
Mechanism of anti-HIV activity of negatively charged albumins: biomolecular interaction with the HIV-1 envelope protein gp120M E Kuipers, J G Huisman, P J Swart, et al.
NPJ Vaccines|December 31, 2019
Adenovectors encoding RSV-F protein induce durable and mucosal immunity in macaques after two intramuscular administrationsN C Salisch, A Izquierdo Gil, D N Czapska-Casey, et al.
Journal of Virology|August 17, 2001
Cytopathicity of human immunodeficiency virus type 1 primary isolates depends on coreceptor usage and not patient disease statusJ F Kreisberg, D Kwa, B Schramm, et al.
AIDS (London, England)|September 8, 2001
Evidence for a post-entry barrier to R5 HIV-1 infection of CD4 memory T cellsA Vyakarnam, J Eyeson, I Teo, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 5, 2000
IL-4 is a mediator of IL-12p70 induction by human Th2 cells: reversal of polarized Th2 phenotype by dendritic cellsP Kaliński, H H Smits, J H Schuitemaker, et al.
The Journal of Infectious Diseases|August 7, 1999
Reduced prevalence of the CCR5 delta32 heterozygous genotype in human immunodeficiency virus-infected individuals with AIDS dementia complexR P van Rij, P Portegies, T Hallaby, et al.
AIDS (London, England)|November 1, 1994
Viro-immunological studies in acute HIV-1 infectionM T Roos, N A de Leeuw, F A Claessen, et al.
Pageof 10

Showing results (61-70 of 92) with videos related to

Sort By:
Pageof 10
The Journal of Infectious Diseases|October 1, 1996
Changes in cellular virus load and zidovudine resistance of syncytium-inducing and non-syncytium-inducing human immunodeficiency virus populations under zidovudine pressure: a clonal analysisA B van 't Wout, M D de Jong, N A Kootstra, et al.
AIDS (London, England)|August 17, 1999
HIV-1 subtype C syncytium- and non-syncytium-inducing phenotypes and coreceptor usage among Ethiopian patients with AIDSA Abebe, D Demissie, J Goudsmit, et al.
Biologicals : Journal of the International Association of Biological Standardization|October 31, 2006
Viral safety of C1-inhibitor NFF G Terpstra, M Kleijn, A H L Koenderman, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|April 15, 1996
Mechanism of anti-HIV activity of negatively charged albumins: biomolecular interaction with the HIV-1 envelope protein gp120M E Kuipers, J G Huisman, P J Swart, et al.
NPJ Vaccines|December 31, 2019
Adenovectors encoding RSV-F protein induce durable and mucosal immunity in macaques after two intramuscular administrationsN C Salisch, A Izquierdo Gil, D N Czapska-Casey, et al.
Journal of Virology|August 17, 2001
Cytopathicity of human immunodeficiency virus type 1 primary isolates depends on coreceptor usage and not patient disease statusJ F Kreisberg, D Kwa, B Schramm, et al.
AIDS (London, England)|September 8, 2001
Evidence for a post-entry barrier to R5 HIV-1 infection of CD4 memory T cellsA Vyakarnam, J Eyeson, I Teo, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 5, 2000
IL-4 is a mediator of IL-12p70 induction by human Th2 cells: reversal of polarized Th2 phenotype by dendritic cellsP Kaliński, H H Smits, J H Schuitemaker, et al.
The Journal of Infectious Diseases|August 7, 1999
Reduced prevalence of the CCR5 delta32 heterozygous genotype in human immunodeficiency virus-infected individuals with AIDS dementia complexR P van Rij, P Portegies, T Hallaby, et al.
AIDS (London, England)|November 1, 1994
Viro-immunological studies in acute HIV-1 infectionM T Roos, N A de Leeuw, F A Claessen, et al.
Pageof 10